Biosimilar medicine authorized by the AEMPS
ACTIVE PRINCIPLE: Enoxaparin Sodium
INDICATION: venous thrombosis
DATE: 27/09/2018
STATUS: Authorized
MORE INFORMATION
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.
SUBSCRIBE
